Literature DB >> 15098089

[Changes in muscarinic receptors of the aging bladder].

K-E Andersson1, A Schröder.   

Abstract

The prevalence of the overactive bladder syndrome (OAB) increases with age. Unfortunately, treatment of the condition is still unsatisfactory. Since muscarinic receptor antagonists are the only effective drug treatment to date, it is logical to assume that muscarinic receptors play an important role in the pathogenesis of OAB. Muscarinic receptors are involved in both the normal and overactive detrusor contraction, and age-dependent changes in muscarinic receptor functions have been found in both animals and human detrusors. In animals as well as humans, two components of detrusor contraction have been demonstrated, the dominating one mediated by muscarinic receptors and the other by ATP (atropine-resistant component). The muscarinic receptor-mediated component decreases with age, and the ATP (purinergic) part increases. However, the clinical consequence of this is unclear, since no major age-dependent changes in the efficacy of antimuscarinic agents in the treatment of OAB have been demonstrated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098089     DOI: 10.1007/s00120-004-0565-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  67 in total

1.  Distribution of P2X receptors in the urinary bladder and the ureter of the rat.

Authors:  H Y Lee; M Bardini; G Burnstock
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

2.  Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles.

Authors:  M Yoshida; Y Homma; A Inadome; M Yono; H Seshita; Y Miyamoto; S Murakami; K Kawabe; S Ueda
Journal:  Exp Gerontol       Date:  2001-01       Impact factor: 4.032

3.  Focal changes in nerve, muscle and connective tissue in normal and unstable human bladder.

Authors:  R G Charlton; A R Morley; P Chambers; J I Gillespie
Journal:  BJU Int       Date:  1999-12       Impact factor: 5.588

4.  P2X receptors and their role in female idiopathic detrusor instability.

Authors:  Barry A O'Reilly; Alan H Kosaka; Gillian F Knight; Thomas K Chang; Anthony P D W Ford; Janice M Rymer; Rick Popert; Geoffrey Burnstock; Stephen B McMahon
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

5.  Muscarinic inhibition of ATP-sensitive K+ channels by protein kinase C in urinary bladder smooth muscle.

Authors:  A D Bonev; M T Nelson
Journal:  Am J Physiol       Date:  1993-12

6.  Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype.

Authors:  G D'Agostino; M L Bolognesi; A Lucchelli; D Vicini; B Balestra; V Spelta; C Melchiorre; M Tonini
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

7.  Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence.

Authors:  K H Moore; F R Ray; J A Barden
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 8.  The unstable detrusor.

Authors:  Paul Bulmer; Paul Abrams
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

9.  Muscarinic cholinergic receptors in the normal and neurogenic human bladder.

Authors:  H Lepor; D Gup; E Shapiro; M Baumann
Journal:  J Urol       Date:  1989-09       Impact factor: 7.450

10.  Age-related changes in sensitivity of rat urinary bladder to autonomic agents.

Authors:  M G Kolta; L J Wallace; M C Gerald
Journal:  Mech Ageing Dev       Date:  1984-10-15       Impact factor: 5.432

View more
  2 in total

1.  [Postoperative intestinal paralysis caused by the muscarinic receptor blocker tiotropium bromide].

Authors:  G M Praetorius
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

2.  Age-dependent decrease in TRPM4 channel expression but not trafficking alters urinary bladder smooth muscle contractility.

Authors:  Sarah E Maxwell; M Dennis Leo; John Malysz; Georgi V Petkov
Journal:  Physiol Rep       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.